Market Place
Sourcing Support
Nanoform and Takeda to Collaborate on Plasma-Derived Therapy Formulation
15 Aug 2024 //
PR NEWSWIRE
Nanoform Bio-Nanoparticles Showcased Large Pharma Partnering Progresses
30 May 2024 //
PR NEWSWIRE
Nanoform partners with CBC to bring best-in-class nanomedicine tec.to Japan
16 Apr 2024 //
BIOSPECTRUM ASIA
Nanoform, PlusVitech Partner To Repurpose Aprepitant For Lung Cancer
09 Apr 2024 //
PR NEWSWIRE
Nanoform Wins R&D Grant of EUR 4.3M for Research
15 Feb 2024 //
PR NEWSWIRE
Nanoform Announces Milestone with Promising Clinical Results for Enzalutamide
26 Jan 2024 //
PR NEWSWIRE
Nanoform Commenced Relative Bioavailability Study of Enzalutamide
05 Jan 2024 //
PR NEWSWIRE
Nanoform grant Global STARMAP® AI License to AstraZeneca
23 Oct 2023 //
PR NEWSWIRE
Nanoform & Celanese demonstrate enhanced drug delivery through smaller implants
19 Jun 2023 //
INDIANPHARMAPOST
China clears sNDA for combination therapy of NSCLC
10 May 2023 //
PHARMACEUTICAL TECHNOLOGY
Nanoform signs GMP mfg program with TargTex following formulation success
04 Feb 2022 //
PRNEWSWIRE
Nanoform signs GMP mfg. program with TargTex following formulation success
04 Feb 2022 //
PRNEWSWIRE
Nanoform Interim Report January - September 2021
25 Nov 2021 //
PRNEWSWIRE
Nanoform Signs GMP API Pact for Marketed Drug
16 Nov 2021 //
CONTRACTPHARMA
Nanoform signs GMP agreement and achieves near-term business target
15 Nov 2021 //
PRNEWSWIRE
Nanoform Shortlisted For The European Small and Mid-Cap Awards 2021
23 Sep 2021 //
PRNEWSWIRE
Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
22 Apr 2021 //
CONTRACTPHARMA
Nanoform and Aprecia Explore 3D-Printed Drug Dosage Forms
21 Apr 2021 //
PHARMTECH
Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines
21 Apr 2021 //
PRNEWSWIRE
Nanoform and Nacuity Pharmaceuticals Sign Technology Proof of Concept ("PoC")
31 Mar 2021 //
PRNEWSWIRE
Nanoform and Nacuity Pharmaceuticals Sign Technology Proof of Concept ("PoC")
30 Mar 2021 //
PRNEWSWIRE
Nanoform`s Clinical Study Indicates Positive Interim Results
22 Jan 2021 //
PRNEWSWIRE
Nanoform`s Clinical Study Indicates Positive Interim Results
22 Jan 2021 //
PRNEWSWIRE
Nanoform`s Clinical Study Indicates Positive Interim Results
22 Jan 2021 //
PRNEWSWIRE
Nanoform Finland begins patient dosing in ph1 human trial of nanoformed drug
22 Dec 2020 //
PHARMABIZ
First dosing of nanoformed drug successfully accomplished
22 Dec 2020 //
PRNEWSWIRE
First dosing of nanoformed drug successfully accomplished
21 Dec 2020 //
PRIVATE EQUITYWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.